 Stockopedia |
CORRECT: Vectura Licenses Patents To GlaxoSmithKline
Wall Street Journal VX) generics unit Sandoz handed back the US rights to VR315, a generic version of an asthma drug, to Vectura. Analysts said it signaled Sandoz wasn't sure … INTERVIEW: Vectura Patents For GSK's 573719 And 642444 Vectura and GlaxoSmithKline sign agreement over asthma patents Vectura boosted by deal with GSK worth over $30 million upfront plus royalties … |
View full post on asthma – Google News